Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Merkt

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|October 29, 2024
Comment on: Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission: ReplyWolfgang Merkt, Manuel Röhrich
Rheumatology (Oxford, England)|March 9, 2024
CD19.CAR T cells versus obinutuzumab-who will win the race for use in deep B cell depletion therapy in systemic autoimmunity?Peter Kvacskay, Wolfgang Merkt
Arthritis Research & Therapy|September 16, 2016
Rituximab induces phenotypical and functional changes of NK cells in a non-malignant experimental settingWolfgang Merkt, Hanns-Martin Lorenz, Carsten Watzl
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2017
Rituximab and Fcγ Receptors in Granulomatosis With Polyangiitis (Wegener's): Comment on the Article by Cartin-Ceba et alWolfgang Merkt, Hanns-Martin Lorenz, Carsten Watzl
Zeitschrift Fur Rheumatologie|November 26, 2025
[Arthralgia and clubbing of the fingers lead to diagnosis of bronchial carcinoma]Franca Deicher, Laura-Marie Lahu, Wolfgang Merkt
The New England Journal of Medicine|May 1, 2024
CAR T-Cell Therapy in Autoimmune DiseaseWolfgang Merkt, Hanns-Martin Lorenz, Michael Schmitt
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|June 12, 2021
Myofibroblast fate plasticity in tissue repair and fibrosis: Deactivation, apoptosis, senescence and reprogrammingWolfgang Merkt, Yan Zhou, Hongwei Han, et al.
Zeitschrift Fur Rheumatologie|September 1, 2025
[Experiences after CD19-CAR T-cell therapy in non-SLE connective tissue diseases]Wolfgang Merkt, Jörg Henes, Christina Bergmann, et al.
Rheumatology (Oxford, England)|April 19, 2022
Leflunomide in combination with JAK inhibitors in the treatment of rheumatoid arthritis: a case seriesPeter Kvacskay, Nobert Blank, Hanns-Martin Lorenz, et al.
Seminars in Cell & Developmental Biology|December 28, 2019
Senotherapeutics: Targeting senescence in idiopathic pulmonary fibrosisWolfgang Merkt, Marta Bueno, Ana L Mora, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|October 29, 2024
Comment on: Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission: ReplyWolfgang Merkt, Manuel Röhrich
Rheumatology (Oxford, England)|March 9, 2024
CD19.CAR T cells versus obinutuzumab-who will win the race for use in deep B cell depletion therapy in systemic autoimmunity?Peter Kvacskay, Wolfgang Merkt
Arthritis Research & Therapy|September 16, 2016
Rituximab induces phenotypical and functional changes of NK cells in a non-malignant experimental settingWolfgang Merkt, Hanns-Martin Lorenz, Carsten Watzl
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2017
Rituximab and Fcγ Receptors in Granulomatosis With Polyangiitis (Wegener's): Comment on the Article by Cartin-Ceba et alWolfgang Merkt, Hanns-Martin Lorenz, Carsten Watzl
Zeitschrift Fur Rheumatologie|November 26, 2025
[Arthralgia and clubbing of the fingers lead to diagnosis of bronchial carcinoma]Franca Deicher, Laura-Marie Lahu, Wolfgang Merkt
The New England Journal of Medicine|May 1, 2024
CAR T-Cell Therapy in Autoimmune DiseaseWolfgang Merkt, Hanns-Martin Lorenz, Michael Schmitt
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|June 12, 2021
Myofibroblast fate plasticity in tissue repair and fibrosis: Deactivation, apoptosis, senescence and reprogrammingWolfgang Merkt, Yan Zhou, Hongwei Han, et al.
Zeitschrift Fur Rheumatologie|September 1, 2025
[Experiences after CD19-CAR T-cell therapy in non-SLE connective tissue diseases]Wolfgang Merkt, Jörg Henes, Christina Bergmann, et al.
Rheumatology (Oxford, England)|April 19, 2022
Leflunomide in combination with JAK inhibitors in the treatment of rheumatoid arthritis: a case seriesPeter Kvacskay, Nobert Blank, Hanns-Martin Lorenz, et al.
Seminars in Cell & Developmental Biology|December 28, 2019
Senotherapeutics: Targeting senescence in idiopathic pulmonary fibrosisWolfgang Merkt, Marta Bueno, Ana L Mora, et al.
Pageof 4